IP Library Granted Patent US 7,744,590
Granted Patent B2
US 7,744,590 · App. 12/056,458 · Granted Jun 29, 2010

Red to near-infrared photobiomodulation treatment of the visual system in visual system disease or injury

Assignee: Medical College of Wisconsin Research Foundation, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,744,590
App. No.
12/056,458
Granted
Jun 29, 2010
Kind
B2
Abstract

A method of treating visual system disease is disclosed. One embodiment comprises the steps of (a) exposing a component of a patient's visual system to light treatment, wherein the light treatment is characterized by wavelength of between 630-1000 nm and power intensity between 10-90 mW/cm 2 for a time of 1-3 minutes, and (b) observing restoration of visual system function.

Claims (23)

1. A method of treating visual system disease or injury, comprising the steps of

a) exposing a component of a patient's visual system to light treatment in the absence of an exogenous photosensitizer, wherein the light treatment is characterized by a wavelength of 630-1000 nm and power intensity between 10-90 mW/cm 2 , and

b) performing one or more tests measuring visual function, wherein the test results indicate an increase in metabolically active neurons.

2. The method of claim 1 wherein the wavelength is selected from the group consisting of 670 nm, 830 nm and 880 nm.

3. The method of claim 1 wherein the wavelength is between 670-900 nm.

4. The method of claim 1 wherein the light treatment is characterized by an energy density of between 0.5-20 J/cm 2 .

5. The method of claim 4 when the energy density is between 2-10 j/cm 2 .

6. The method of claim 1 wherein the patient is exposed to light treatment multiple times.

7. The method of claim 6 wherein the exposure is at least 3 times.

8. The method of claim 6 wherein the patient is exposed to light treatment at intervals of 24 hours.

9. The method of claim 1 wherein the component of the visual system comprises the patient's retina.

10. The method of claim 1 wherein the component of the visual system is selected from the group consisting of cornea and optic nerve.

11. The method of claim 1 wherein the retinal function is evaluated.

12. The method of claim 1 wherein the light is supplied by an LED device.

13. The method of claim 1 wherein the power intensity is between 25-50 mW/cm 2 .

14. A method of treating visual system disease or injury, comprising the steps of

a) exposing a component of a patient's visual system to light treatment in the absence of an exogenous photosensitizer, wherein the light treatment is characterized by wavelength of 630-1000 nm and power intensity between 10-90 mW/cm 2 , and

b) performing electroretinography (ERG) to observe restoration or protection of visual function, wherein rod and cone ERG amplitude has increased relative to tissue that hasn't been exposed to the light treatment.

15. The method of claim 14 wherein the light treatment is applied for a time of 1-3 minutes.

16. The method of claim 14 wherein the light is supplied by an LED device.

17. The method of claim 1 wherein the light treatment is applied for a time of 1-3 minutes.

18. The method of claim 1 wherein the light treatment is applied at least 2-3 times a day.

19. The method of claim 1 wherein the patient is a human.

Assignments (2)
CONFIRMATORY LICENSE Recorded May 23, 2011
From: MEDICAL COLLEGE OF WISCONSIN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026320/0477 →
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Jan 9, 2009
From: MEDICAL COLLEGE OF WISCONSIN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022080/0867 →
Continuity (3)
Continuation 1075879300 · Jan 16, 2004
Provisional Application 6044081600 · Jan 17, 2003
Related Publication 20090062888A1 · Mar 5, 2009